Gygax, DanielEigenmann, KasparSuter, ChristianHürzeler Müller, MarianneMahmoud, AhmedMosbacher, JohannesPöllinger, Norbert2024-02-082024-02-0820232673-24240009-429310.2533/chimia.2023.616https://irf.fhnw.ch/handle/11654/44076https://doi.org/10.26041/fhnw-7963In this work, we investigated the technical feasibility of 'on-demand' production of selected drugs to cover their demand for a time window of 90 days. We focused on two sub-processes 'automated chemical synthesis' and 'formulation in micropellets'  to enable personalized dosing. The production of drugs 'on-demand' is challenging, important, but also attractive. Switzerland could thus gain access to an additional instrument for increasing resilience for supply-critical drugs. The biggest challenge in the case study presented here is the scalability of automated chemical synthesis and the application range of micropellet formulations.enAutomation of chemical synthesisMicropellet formulationOn-demand productionPersonalized healthcare500 - Naturwissenschaften und Mathematik01A - Beitrag in wissenschaftlicher Zeitschrift616-619